Pain Clinical Trial
Official title:
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Evidence to support the effectiveness of ongoing opioid therapy for the treatment of chronic non-malignant pain is lacking. In fact, data suggest that patient outcomes improve when tapered off opioid analgesics. To better understand the role opioid therapy plays in the experience of pain, we will study measured pain sensitivity in opioid dependent patients over the course of and 3 months following a standardized opioid taper. By isolating the effect of opioid taper in patients without pain, preliminary evidence of effect size can be used to guide clinicians treating patients with chronic pain.
Chronic pain impacts the daily lives of fully one-third of Americans over the age of 45, with
prevalence expected to increase as the population ages. In well-intended and industry-driven
efforts to provide relief to chronic pain sufferers, the prescription of opioids has
increased dramatically since the turn of the century, such that it is currently estimated
that between 5 and 8 million Americans use opioids on a daily basis for chronic pain
management. Yet, prescription opioid therapy for chronic pain is not an evidence-based
intervention. In fact, as evaluation data accumulate, it is becoming clear that outcomes are
often poorer for patients on opioid therapy, and that improvements are appreciated when
tapered off the medications. In the midst of an "epidemic of prescription drug abuse" it is
critical that opioid prescription practices be evidence-based and delivered "in the best
possible manner that maximizes effectiveness and minimizes harm".
A theorized explanation for poorer outcomes (functionality, quality of life) for patients on
opioid therapy is the phenomenon of opioid-induced hyperalgesia (OIH). Well-demonstrated in
animal and inferred in patients, ongoing opioid use results in increased sensitivity to
experimental pain, which, in the case of the chronic pain patient, is believed to interfere
with (if not preclude) desired pain relief outcomes. However, the causal relationship between
opioid discontinuation and OIH has received little empirical attention, such that it is not
clear the degree to which opioid taper improves pain responses and outcomes, if at all.
Evidence supporting that prescription opioids makes the pain experience worse for chronic
pain patients would support a sea change in current practice of chronic opioid therapy.
Studying the direct effects of an opioid taper on pain responses in chronic pain patients is
challenging; complicated by the reemergence of pain, variable compliance with taper and
concomitant increased use of non-opioid pain medications, a controlled examination of pain
responses during and following opioid detoxification is not immediately tenable in this
patient population. Thus, funded is a proof-of concept trial to identify and characterize the
direct effects of opioid detoxification on experimental pain responses in opioid-dependent
patients without chronic pain to establish if, in fact, a notable effect size can be
discerned. If supported, these findings will provide a foundation upon which to predict
efficacy in patients with the more complicated picture of chronic pain.
Specifically, in a well-characterized sample of men and women seeking addiction treatment in
a residential setting, experimental pain responses will be serially described over the course
of and for three months following a standard observed opioid (buprenorphine) taper, and
compared to those of matched control patients initiated on buprenorphine maintenance therapy.
Pain responses will be measured with two valid and reliable experimental pain induction
techniques commonly used to measure OIH (cold-pressor, quantitative sensory testing), and
subject-level predictors of response identified.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|